Evidence map›Paper›PMID 41701299›Full record

ArticleClinical autonomic research : official journal of the Clinical Autonomic Research Society2026

Losartan treatment attenuates the cardiorenal alterations in a rat model of hemorrhagic insular stroke.

Liliane Ramos Dos Santos Machado, Itamar Couto Guedes Jesus, Marcos Eliezeck, Ana Caroline Ventris de Godoy, Matheus Henrique da Silva Cruz, Vanessa Pinho, Aline Silva de Miranda, Diogo Barros Peruchetti, Maria José Campagnole-Santos, Robson Augusto Souza Dos Santos and 2 more

Abstract readLetter
PubMed Publisher
In one paragraph

Article in Clinical autonomic research : official journal of the Clinical Autonomic Research Society, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Liliane Ramos Dos Santos MachadoDepartment of Physiology and Biophysics, National Institute of Science and Technology in Nanobiopharmaceutics (INCT Nanobiofar), ICB, Federal University of Minas Gerais, Belo Horizonte, MG, 31270 901, Brazil.
Itamar Couto Guedes JesusDepartment of Physiology and Biophysics, National Institute of Science and Technology in Nanobiopharmaceutics (INCT Nanobiofar), ICB, Federal University of Minas Gerais, Belo Horizonte, MG, 31270 901, Brazil.
Marcos EliezeckDepartment of Physiology and Biophysics, National Institute of Science and Technology in Nanobiopharmaceutics (INCT Nanobiofar), ICB, Federal University of Minas Gerais, Belo Horizonte, MG, 31270 901, Brazil.
Ana Caroline Ventris de GodoyDepartment of Physiology and Biophysics, National Institute of Science and Technology in Nanobiopharmaceutics (INCT Nanobiofar), ICB, Federal University of Minas Gerais, Belo Horizonte, MG, 31270 901, Brazil.
Matheus Henrique da Silva CruzDepartment of Physiology and Biophysics, National Institute of Science and Technology in Nanobiopharmaceutics (INCT Nanobiofar), ICB, Federal University of Minas Gerais, Belo Horizonte, MG, 31270 901, Brazil.
Vanessa PinhoDepartment of Morphology, ICB, Federal University of Minas Gerais, Belo Horizonte, Brazil.
Aline Silva de MirandaDepartment of Morphology, ICB, Federal University of Minas Gerais, Belo Horizonte, Brazil.
Diogo Barros PeruchettiDepartment of Physiology and Biophysics, National Institute of Science and Technology in Nanobiopharmaceutics (INCT Nanobiofar), ICB, Federal University of Minas Gerais, Belo Horizonte, MG, 31270 901, Brazil.
Maria José Campagnole-SantosDepartment of Physiology and Biophysics, National Institute of Science and Technology in Nanobiopharmaceutics (INCT Nanobiofar), ICB, Federal University of Minas Gerais, Belo Horizonte, MG, 31270 901, Brazil.
Robson Augusto Souza Dos SantosDepartment of Physiology and Biophysics, National Institute of Science and Technology in Nanobiopharmaceutics (INCT Nanobiofar), ICB, Federal University of Minas Gerais, Belo Horizonte, MG, 31270 901, Brazil.
Silvia GuatimosimDepartment of Physiology and Biophysics, National Institute of Science and Technology in Nanobiopharmaceutics (INCT Nanobiofar), ICB, Federal University of Minas Gerais, Belo Horizonte, MG, 31270 901, Brazil.
Marco Antônio Peliky FontesDepartment of Physiology and Biophysics, National Institute of Science and Technology in Nanobiopharmaceutics (INCT Nanobiofar), ICB, Federal University of Minas Gerais, Belo Horizonte, MG, 31270 901, Brazil. peliky@icb.ufmg.br.ORCID http://orcid.org/0000-0003-4525-3565

Funding

Conselho Nacional de Desenvolvimento Científico e Tecnológico CNPq INCT 406792/2022-4Conselho Nacional de Desenvolvimento Científico e Tecnológico CNPq PQ 308923/2021-9Fapemig APQ-01128-21
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

AutonomicCardiovascularCortexInsulaLosartanRatsStroke

Identifiers

PMID41701299

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.